244/250) 2 Viruses proliferate through both genome replication inside infected cells and 3 transmission to new target cells or to new hosts. Each viral genome molecule in 4 infected cells is used either for amplifying the intracellular genome as a template 5 ("stay-at-home strategy") or for packaging into progeny virions to be released 6 extracellularly ("leaving-home strategy"). The balance between these strategies is 7 important for both initial growth and transmission of viruses. In this study, we used 8 hepatitis C virus (HCV) as a model system to study the functions of viral genomic 9 RNA in both RNA replication in cells and in progeny virus assembly and release.
Introduction 27
Hepatitis C virus (HCV) is an RNA virus specifically infecting liver cells. HCV 28 produces progeny viruses rapidly, with ~10 12 copies sometimes observed in patients 29 [1] . Following virus entry into target cells, viral genomic RNA produces structural 30 proteins (S) and non-structural proteins (NS) (Fig. 1A) . Using the genomic RNA as a 31 template, the viral non-structural proteins amplify HCV RNA ("RNA replication").
32 Genomic RNA can also be assembled with viral structural proteins into progeny 33 virions to be egressed outside of cells, creating the opportunity for transmission (in 34 this study, we call the process including particle assembly and egress "release").
35 Thus, a single HCV genomic RNA molecule can be used either for RNA replication or 36 for release, and the balance between these processes governs viral proliferation. The 37 molecular mechanisms underlying each event in the viral life cycle have been 38 extensively investigated [2, 3], yet the replication-release trade-off and its significance 39 for viral proliferation remain poorly understood.
40
HCV JFH-1 is a genotype 2a strain isolated by our group from a patient with 44 genome from the core to NS2 was replaced by sequences from another genotype 2a 45 virus, the J6 strain) was developed as a laboratory strain to improve virus production, 46 and used for development of antiviral agents and vaccines, which requires large 47 amounts of virus [5, 6] . In spite of their high sequence similarity (97% identity over the 48 whole genome), these two viruses have different virological characteristics especially 49 in terms of the release process: while JFH-1 particles assemble on lipid droplet 50 membranes, particle assembly of J6/JFH-1-chimeric lab strains is associated with 51 endoplasmic reticulum-derived membranes [2, 3]. Thus, these two related strains are 52 a useful a reference set to compare the dynamics of release and RNA replication.
53
In this study, we used a cell culture model of infection with these two HCV 54 reference strains and measured the time-course of viral production (including HCV 55 RNA inside cells and virions produced outside of the cells), infectivity of progeny HCV, 56 and infected cell numbers. We also developed a multiscale mathematical model to 57 describe intra-and inter-cellular HCV dynamics. This interdisciplinary approach 58 suggests that different strategies exist for viral proliferation: the stay-at-home strategy 59 (JFH-1) and the leaving-home strategy (Jc1-n, a J6/JFH-1-chimeric strain). We 60 discuss the relevance of these strategies for viral proliferation, while referring to [7] for 61 wider evolutionary context.
Results
63 Age-structured multiscale modeling of HCV infection
64
To describe the intracellular replication dynamics of HCV viral RNA, we used 65 the following mathematical model:
67 where is the amount of intracellular viral RNA in cells that have been infected ( ) 68 for time . The intracellular viral RNA replicates at rate , degrades at rate , and is 69 released to extracellular space at rate ( Fig. 1B) . Note that if viruses have small or 70 large , then they tend to stay inside or leave the cell, respectively (see later). In our 71 virus experiments (see Methods), the released viruses could infect other target cells.
72 To describe multi-round virus transmission (i.e., de novo infection), we needed to 73 couple intracellular viral replication with a standard mathematical model for 74 intercellular virus infection in cell culture [8, 9] (Fig. 1C) . In Supplementary Note 1, 75 we derived the following multiscale ordinary differential equation (ODE) model for 76 HCV infection from the corresponding age-structured partial differential equation 103 Experimental measurements below the detection limit were excluded in the fitting.
104 The estimated parameters and initial values are listed in Table 1 and Table S1 . The 105 typical behavior of the model using these best-fit parameter estimates is shown 106 together with the data in Fig. 2A for HCV JFH-1 (orange) and Jc1-n (green) (see 107 Methods for HCV strains), and indicated that Eqs. (2-6) described the in vitro data 108 very well. The shadowed regions corresponded to 95% posterior predictive intervals, 109 the solid and dashed lines gave the best-fit solution (mean) for Eqs. (2-6), and the 110 orange circles and green triangles showed the experimental datasets.
111
Using the estimated parameters shared between the original PDE model in 112 Supplementary Note 1 and the transformed ODE model (i.e., Eqs. (2-6)), we 113 successfully reconstructed age information for intracellular viral RNA in infected cells 7 115 ( Fig. 2B ). Fig. 2C shows the differences in intracellular JFH-1 and Jc1-n viral RNA 116 levels in cells of infection age . At the beginning of the experiment, intracellular viral 117 RNA increased faster under Jc1-n infection than under JFH-1 infection (shown in 118 green). However, intracellular JFH-1 viral RNA gradually accumulated to higher levels 119 than Jc1-n at later time points after infection (shown in yellow to brown). These data 120 illustrated the different dynamics of these two strains and the impact of these 121 dynamics on intracellular viral RNA production, all resulting from different strategies 122 to transmit the viral genome (see below).
123
124 Dynamics of HCV JFH-1 and Jc1-n strain replication 133 bootstrap t-test) (Fig. 3A) . In addition, the release rate of intracellular viral RNA, , 134 for JFH-1 and Jc1-n were (95% CI: ) and 2.43 × 10 -2 1.87 -3.11 × 10 -2 6.25 × 135 (95% CI: ), respectively ( by repeated 10 -2 4.62 -8.44 × 10 -2 = 2.00 × 10 -6
136 bootstrap t-test) (Fig. 3B) . These estimates indicated that Jc1-n infects cells 1.71
137 times faster and produces progeny viruses from infected cells 2.57 times faster than 138 JFH-1. The estimate was further validated by independent experiments, in which 139 Jc1-n entry and virus production were indeed significantly higher than those of JFH-1 Note 2 and Fig. S2 ). There was also a small but significant 141 difference between the degradation rate, , of JFH-1 ( , 95% CI: ) and 0.78 0.77 -0.78
(Supplementary
142 Jc1-n ( , 95% CI: ) ( Fig. 3C ). No significant difference was apparent in 0.83 0.80 -0.84
143 the converted fraction of infectious virus, (Fig. 3D) . Because JFH-1 and Jc1-n 144 have identical non-structural regions essential for RNA replication (NS3-NS5B), we 145 estimated the same viral RNA replication rate, , for these two viruses ( Fig. 3E) .
146 Hence, our parameter estimation captured the characteristics of the two strains well 147 and was able to quantitatively describe viral infection dynamics.
148
In our multiscale model (Eqs. (2-6)), the accumulation rate of intracellular 150 the degradation rate and the release rate (i.e., ). The distributions of --151 calculated intracellular RNA accumulation rates for JFH-1 ( , 95% CI: ) 153 bootstrap t-test) ( Table 1) . The preferential accumulation of JFH-1 RNA inside cells 154 was consistent with its tendency toward gradual increased levels of intracellular RNA 155 at later time points (Fig. 2C) . To further evaluate total viral RNA level considering 160 The Malthusian parameters for JFH-1 and Jc1-n were calculated as (95% CI: 1.11
161
) and (95% CI: ), respectively, and were significantly 1.04 -1.18 1.02 0.95 -1.09
162 different from one another ( by bootstrap t-test) ( Fig. 3G and Table 1 ). = 1.02 × 10 -3 163 Interestingly, even if Jc1-n had a larger infection rate, , and release rate, ,
164 compared with JFH-1, the initial growth rate of total JFH-1 RNA was higher than that 165 of Jc1-n. This result demonstrated that the capacity to accumulate viral RNA inside 166 cells predominantly determines the initial growth rate rather than release of progeny 167 viruses.
168
169 Stay-at-home strategy or leaving-home strategy for "optimizing" HCV 170 proliferation
171
We investigated how differences between the two strains, JFH-1 and Jc1-n, 172 might be interpreted in an evolutionary perspective. As mentioned above, we 173 considered two opposing strategies: the "stay-at-home strategy" and the 174 "leaving-home strategy": If viruses have smaller , they preferentially stay inside the 175 cell, but if they have larger , they leave the cell. To quantitatively characterize these 176 different strategies, we defined the fraction of viral RNA remaining in the cells ( 177 ), released from the cells ( ), and degraded in the cells ( ) within the ( --)/ / / 178 total intracellular viral RNA produced (Fig. 4A) . Using all accepted MCMC parameter 179 estimates from the time-course experimental datasets, we calculated that the 180 fractions of viral RNA remaining were 57.9% and 53.5%, the fractions of viral RNA 181 degraded were 40.8% and 43.2%, and the fractions of viral RNA released were 182 1.27% and 3.28% for JFH-1 and Jc1-n, respectively (Fig. 4B) . Notably, Jc1-n used 183 intracellular viral RNA for virus release 2.58 times faster than JFH-1, explaining the 184 rapid transmission of Jc1-n ( Fig. 2C) . These results indicate the preferential 185 "leaving-home" strategy of Jc1-n as compared with JFH-1, which adopts a 186 "stay-at-home" strategy.
187
To further investigate these two opposing strategies, we addressed the 188 relevance of viral RNA release rates for viral proliferation using in silico analysis. With
189 various values of the release rate of intracellular viral RNA, , we calculated the 190 Malthusian parameter for each strain as an indicator of viral fitness (Fig. 4C) . Each 203 We also calculated the cumulative number of newly infected cells for each strain 204 using the means of the estimated parameters as functions of (Fig. 4D) . Thus, it appears that Jc1-n is more optimized for producing 213 newly infected cells. This implies that HCV Jc1-n adopts the leaving-home strategy to 214 acquire an advantage in producing newly-infected cells.
215
Taken together, our theoretical investigation based on viral infection 216 experiments revealed that the JFH-1 strain optimizes its initial growth rate, but the 217 Jc1-n strain optimizes de novo infection. Ours is the first report to quantitatively 218 evaluate these opposing evolutionary strategies and to show their significance for 219 virus proliferation at the intracellular and intercellular levels. 229 obtain experimental measurements with age information, but thanks to the estimated 230 values of these common parameters, we managed to reconstruct age information for 231 intracellular viral RNA (Fig. 2BC) . In addition, comparing the calculated Malthusian 232 parameters and the cumulative number of newly infected cells between the two 233 strains (Fig. 3FG) , we found that the JFH-1 strain had a higher initial growth rate but 234 that Jc1 produced more de novo infections.
235
Based on our results, we propose two opposing strategies for viral 236 proliferation: the "stay-at-home strategy" and the "leaving-home strategy." From an 237 evolutionary perspective, JFH-1 adopts a stay-at-home strategy and preferentially 238 uses viral genomic RNA for increasing intracellular replication. In contrast, adopting a 239 leaving-home strategy, Jc1-n uses more viral genomic RNA for producing progeny 240 virions capable of new transmission events to increase the number of infected cells 241 (Fig. 4) . Thus, Jc1-n infects cells 1.71 times faster and produces viral RNA from 242 infected cells 2.57 times faster than JFH-1. Our group and others reported that JFH-1 243 assembled progeny virions on the membranes of hepatic lipid droplets, while 244 J6/JFH-1 chimeric strains mainly used endoplasmic reticulum-derived membranes for 245 particle production [2, 3]. Although the molecular aspects of this difference have been 246 analyzed, its significance for viral proliferation and dynamics is not completely 247 understood. Our results raise the possibility that different subcellular locations for 248 particle assembly impact the rates of particle assembly and release, which in turn 249 determine virus proliferation. Further analysis might shed light on why one HCV strain 250 has to be assembled on the lipid droplet membrane while another assembles in 251 association with the endoplasmic reticulum.
252
The choice of replication strategy not only determines virus proliferation but 253 also affects the pathogenic features of the virus: JFH-1, which preferentially amplifies 12 255 inflammation. By contrast, J6, the original strain encoding the Jc1-n structural region, 256 was isolated from a patient with chronic hepatitis and generally replicates more 284 Note 3) and fixed at and , respectively, for the JFH-1 strain, and 0.660 4.12 × 10 4 285 and , respectively, for the Jc1-n strain. A statistical model adopted 0.665 3.75 × 10 4 286 from Bayesian inference assumed that measurement error followed a normal 287 distribution with mean zero and unknown variance (error variance). A distribution of 288 error variance was also inferred using the Gamma distribution as its prior distribution. 293 from the inferred parameter sets ( Fig. 3EF for graphical representation) . A set of 294 computations for Eqs (2-6) with estimated parameter sets gives a distribution of 14 296 predictions. To investigate variation in model predictions, global sensitivity analyses 297 were performed. The range of possible variation is shown in Fig. 2A RNA copies・ffu -1 1.21 × 10 -3 -0.86 1.67 × 10 -3 1.13 × 10 -3 -0.83 1.49 × 10 -3
